A systematic review has found the choice of the intraocular lens (IOL) edge design and the material seem to have a “significant influence” on

Susvimo (ranibizumab 100mg/mL, Roche)1 has been registered by the Therapeutic Goods Administration (TGA) for use with the already approved Contivue ocular implant.2  The registration

Laurence ‘Larry’ Roth, one of the original co-founders of Marchon Eyewear, passed away in September, following a battle with cancer. He was 75.

A new Australian digital health standards body has begun operations, aiming to assess the safety and quality of artificial intelligence (AI) technology that’s not